By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported that its fourth-quarter revenues increased 5 percent, or 3 percent organically, but it fell short of Wall Street's expectations.

The St. Louis-based research and chemical products firm reported total revenues of $610 million for the three-month period ended Dec. 31, compared to $582 million for the fourth quarter of 2010. Analysts, on average, had expected revenues of $626.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.